Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1961 1
1962 1
1964 5
1965 5
1966 4
1967 5
1968 10
1969 14
1970 20
1971 21
1972 24
1973 29
1974 34
1975 55
1976 64
1977 76
1978 40
1979 27
1980 45
1981 45
1982 66
1983 63
1984 78
1985 85
1986 87
1987 85
1988 85
1989 84
1990 121
1991 139
1992 116
1993 188
1994 195
1995 208
1996 225
1997 253
1998 274
1999 285
2000 270
2001 307
2002 347
2003 405
2004 339
2005 415
2006 411
2007 428
2008 441
2009 485
2010 516
2011 521
2012 519
2013 531
2014 558
2015 567
2016 574
2017 588
2018 604
2019 628
2020 614
2021 589
2022 528
2023 493
2024 194

Text availability

Article attribute

Article type

Publication date

Search Results

13,517 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hypersensitivity to chemotherapy"
Page 1
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions.
Garvey LH, Ebo DG, Mertes PM, Dewachter P, Garcez T, Kopac P, Laguna JJ, Chiriac AM, Terreehorst I, Voltolini S, Scherer K. Garvey LH, et al. Allergy. 2019 Oct;74(10):1872-1884. doi: 10.1111/all.13820. Epub 2019 Jun 18. Allergy. 2019. PMID: 30964555 Review.
Perioperative immediate hypersensitivity reactions are rare. Subsequent allergy investigation is complicated by multiple simultaneous drug exposures, the use of drugs with potent effects and the many differential diagnoses to hypersensitivity in the periopera …
Perioperative immediate hypersensitivity reactions are rare. Subsequent allergy investigation is complicated by multiple simultaneous …
Management and preparedness for infusion and hypersensitivity reactions.
Lenz HJ. Lenz HJ. Oncologist. 2007 May;12(5):601-9. doi: 10.1634/theoncologist.12-5-601. Oncologist. 2007. PMID: 17522249 Free article. Review.
BACKGROUND: Like nearly all systemic cancer therapies, monoclonal antibodies are associated with hypersensitivity reactions. This article reviews the characteristics and management of hypersensitivity reactions to monoclonal antibodies and commonly used chemotherapy …
BACKGROUND: Like nearly all systemic cancer therapies, monoclonal antibodies are associated with hypersensitivity reactions. This art …
A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose.
Kennedy NA, Achebe MM, Biggar P, Pöhlmann J, Pollock RF. Kennedy NA, et al. Int J Clin Pharm. 2023 Jun;45(3):604-612. doi: 10.1007/s11096-023-01548-2. Epub 2023 Apr 3. Int J Clin Pharm. 2023. PMID: 37010731 Free PMC article. Review.
Although uncommon, administration of modern IV iron formulations can result in hypersensitivity reactions (HSRs) and, rarely, anaphylactic or anaphylactoid reactions. ...
Although uncommon, administration of modern IV iron formulations can result in hypersensitivity reactions (HSRs) and, rarely, anaphyl …
Cutaneous vasculitis.
Fiorentino DF. Fiorentino DF. J Am Acad Dermatol. 2003 Mar;48(3):311-40. doi: 10.1067/mjd.2003.212. J Am Acad Dermatol. 2003. PMID: 12637912 Review.
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience.
Parisi A, Palluzzi E, Cortellini A, Sidoni T, Cocciolone V, Lanfiuti Baldi P, Porzio G, Ficorella C, Cannita K. Parisi A, et al. Clin Transl Oncol. 2020 Jan;22(1):158-162. doi: 10.1007/s12094-019-02122-x. Epub 2019 Apr 30. Clin Transl Oncol. 2020. PMID: 31041717 Clinical Trial.
One of the major challenges related to solvent-based taxanes administration in clinical practice is the high rate of hypersensitivity reactions (HSRs). Nab-paclitaxel is a solvent-free, albumin-bound, paclitaxel, which minimize the risk of HSR occurrence. ...
One of the major challenges related to solvent-based taxanes administration in clinical practice is the high rate of hypersensitivity …
The impact of vitamin D supplementation as an adjuvant therapy on clinical outcomes in patients with severe atopic dermatitis: A randomized controlled trial.
Mansour NO, Mohamed AA, Hussein M, Eldemiry E, Daifalla A, Hassanin S, Nassar N, Ghaith D, Mohamed Salah E. Mansour NO, et al. Pharmacol Res Perspect. 2020 Dec;8(6):e00679. doi: 10.1002/prp2.679. Pharmacol Res Perspect. 2020. PMID: 33145984 Free PMC article. Clinical Trial.
The patients were randomized to receive either vitamin D 3 1600 IU/day or placebo, plus baseline therapy of topical 1% hydrocortisone cream twice daily for 12 weeks. ...
The patients were randomized to receive either vitamin D 3 1600 IU/day or placebo, plus baseline therapy of topical 1% hydrocortisone …
Allergen immunotherapy.
Frew AJ. Frew AJ. J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S306-13. doi: 10.1016/j.jaci.2009.10.064. J Allergy Clin Immunol. 2010. PMID: 20176266 Review.
Immunotherapy is effective in patients with mild forms of allergic disease and also in those who do not respond well to standard drug therapy. Most SIT is given by means of injection, but there is increasing interest in performing SIT through the sublingual route. . …
Immunotherapy is effective in patients with mild forms of allergic disease and also in those who do not respond well to standard drug …
Latex allergy.
Warshaw EM. Warshaw EM. Skinmed. 2003 Nov-Dec;2(6):359-66. doi: 10.1111/j.1540-9740.2003.02177.x. Skinmed. 2003. PMID: 14673247 Review.
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial.
Guttman-Yassky E, Brunner PM, Neumann AU, Khattri S, Pavel AB, Malik K, Singer GK, Baum D, Gilleaudeau P, Sullivan-Whalen M, Rose S, Jim On S, Li X, Fuentes-Duculan J, Estrada Y, Garcet S, Traidl-Hoffmann C, Krueger JG, Lebwohl MG. Guttman-Yassky E, et al. J Am Acad Dermatol. 2018 May;78(5):872-881.e6. doi: 10.1016/j.jaad.2018.01.016. Epub 2018 Jan 17. J Am Acad Dermatol. 2018. PMID: 29353025 Free PMC article. Clinical Trial.
At 12 weeks, improvements in body surface area involvement in the entire population were significantly stronger in the drug-treated than placebo-treated patients (12.4% 2.4 vs 6.2% 2.7; P = .009), and in the severe AD subset, the decline in Investigator Global Assessment w …
At 12 weeks, improvements in body surface area involvement in the entire population were significantly stronger in the drug-treated t …
Asthma in the elderly.
Braman SS. Braman SS. Clin Geriatr Med. 2003 Feb;19(1):57-75. doi: 10.1016/s0749-0690(02)00052-6. Clin Geriatr Med. 2003. PMID: 12735115 Review.
13,517 results
You have reached the last available page of results. Please see the User Guide for more information.